Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 25,000 shares at $18.61 ($465K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Open-market sale of $465k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |
| DAWN | SELL | 2022-11-03 | $300K | — | Filing → |